ScarX announces approval for trial of first clinically-promising scar reduction cream

Edit Nasdaq Globe Newswire 18 Aug 2016
18, 2016 (GLOBE NEWSWIRE) -- Toronto-based ScarX Therapeutics (ScarX) has received approval from Health Canada to begin a Phase I clinical trial of its SCX-001 nefopam cream, a first-of-its-kind topical treatment developed to significantly reduce surgical scarring....

Concordia Healthcare Announces Launch of First Pipeline Product, and Positive Amendment to Earn-out Terms of ...

Edit Stockhouse 23 Nov 2015
CXR) announced today that Amdipharm Mercury Limited ("AMCo") has launched Nefopam, a generic version of Accupan. Nefopam is a non-narcotic painkiller for the treatment of persistent pain that is not being controlled by other painkillers such as paracetamol or aspirin ... Nefopam is the first generic to market in the United Kingdom in a drug class growing at approximately five per cent annually....

Global and Chinese Nefopam Hydrochloride Industry: 2009-2019

Edit Business Wire 27 Feb 2015
DUBLIN--(BUSINESS WIRE)--Research and Markets (http.//www.researchandmarkets.com/research/v9d4b7/global_and) has announced the addition of the "Global and Chinese Nefopam Hydrochloride Industry, 2009-2019" report to their offering. Market Research Report on Global and Chinese Nefopam Hydrochloride Industry, 2009-2019 is a professional and in-depth market survey on Global and Chinese Nefopam Hydrochloride industry....
×